Literature DB >> 27478106

Candida albicans colonisation, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study.

Jill L Campbell1,2, Fiona M Coyer2,3,4, Alison M Mudge5, Ivan M Robertson6, Sonya R Osborne2,7,8.   

Abstract

Candida albicans is the most prevalent human fungal commensal organism and is reported to be the most frequent aetiological organism responsible for infection associated with incontinence-associated dermatitis. However, it remains unclear whether incontinence predisposes a patient to increased Candida colonisation or whether incontinence acts as a trigger for Candida infection in those already colonised. The purpose of this observational cross-sectional study was to estimate colonisation rates of C. albicans in continent, compared to incontinent patients, and patients with incontinence-associated dermatitis. Data were collected on 81 inpatients of a major Australian hospital and included a pelvic skin inspection and microbiological specimens to detect C. Albicans at hospital admission. The mean age of the sample was 76 years (SD = 12.22) with 53% being male. Incontinent participants (n = 53) had a non-significant trend towards greater Candida colonisation rates at the perianal site (43% versus 28%) χ2 (1, N = 81) = 4·453, p = ·638 and the inguinal site (24% versus 14%) χ2 (1, N = 81) = 6·868, p = ·258 compared to continent patients (n = 28). The incontinent subgroup with incontinence-associated dermatitis (n = 22) showed no difference in colonisation rates compared to those without incontinence-associated dermatitis. Understanding the epidemiology of colonisation may have implications for the prevention of Candida infection in these patients.
© 2016 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Candida albicans; colonisation; cross-sectional study; incontinence; incontinence-associated dermatitis

Mesh:

Substances:

Year:  2016        PMID: 27478106      PMCID: PMC7949526          DOI: 10.1111/iwj.12630

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  34 in total

Review 1.  Prevention and management of incontinence-associated dermatitis.

Authors:  Denise Nix; Vicki Haugen
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

2.  Vaginal candidiasis and the role of the digestive tract as a source of infection.

Authors:  A L Hilton; D W Warnock
Journal:  Br J Obstet Gynaecol       Date:  1975-11

Review 3.  Incontinence-associated dermatitis: a consensus.

Authors:  Mikel Gray; Donna Z Bliss; Dorothy B Doughty; JoAnn Ermer-Seltun; Karen L Kennedy-Evans; Mary H Palmer
Journal:  J Wound Ostomy Continence Nurs       Date:  2007 Jan-Feb       Impact factor: 1.741

Review 4.  Inflammation and gastrointestinal Candida colonization.

Authors:  Carol A Kumamoto
Journal:  Curr Opin Microbiol       Date:  2011-07-28       Impact factor: 7.934

5.  What is subjective global assessment of nutritional status?

Authors:  A S Detsky; J R McLaughlin; J P Baker; N Johnston; S Whittaker; R A Mendelson; K N Jeejeebhoy
Journal:  JPEN J Parenter Enteral Nutr       Date:  1987 Jan-Feb       Impact factor: 4.016

6.  Skin flora of infants with napkin rash.

Authors:  D B Brookes; R M Hubbert; I Sarkany
Journal:  Br J Dermatol       Date:  1971-09       Impact factor: 9.302

7.  Role of Candida albicans infection in napkin rashes.

Authors:  P N Dixon; R P Warin; M P English
Journal:  Br Med J       Date:  1969-04-05

8.  Yeasts in a hospital for patients with skin diseases.

Authors:  D A Somerville
Journal:  J Hyg (Lond)       Date:  1972-12

9.  International prevalence measurement of care problems: results.

Authors:  Ruud J G Halfens; Esther Meesterberends; Noémi C van Nie-Visser; Christa Lohrmann; Silvia Schönherr; Judith M M Meijers; Sabine Hahn; Christa Vangelooven; Jos M G A Schols
Journal:  J Adv Nurs       Date:  2013-09       Impact factor: 3.187

Review 10.  Incontinence-associated dermatitis: consensus statements, evidence-based guidelines for prevention and treatment, and current challenges.

Authors:  Dorothy Doughty; Joan Junkin; Peter Kurz; Joan Selekof; Mikel Gray; Mandy Fader; Donna Z Bliss; Dimitri Beeckman; Susan Logan
Journal:  J Wound Ostomy Continence Nurs       Date:  2012 May-Jun       Impact factor: 1.741

View more
  7 in total

1.  The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to monitor the healing of incontinence-associated dermatitis (IAD): Design and reliability study.

Authors:  Karen Van den Bussche; Sofie Verhaeghe; Ann Van Hecke; Dimitri Beeckman
Journal:  Int Wound J       Date:  2018-05-24       Impact factor: 3.315

2.  Design and psychometric testing of the attitude towards the prevention of incontinence-associated dermatitis instrument (APrIAD).

Authors:  Nele Van Damme; Ann Van Hecke; Annelies Himpens; Sofie Verhaeghe; Dimitri Beeckman
Journal:  Int Wound J       Date:  2018-12-26       Impact factor: 3.315

Review 3.  [Incontinence-associated dermatitis: a position paper].

Authors:  J Kottner; N Kolbig; A Bültemann; J Dissemond
Journal:  Hautarzt       Date:  2020-01       Impact factor: 0.751

Review 4.  Contact Dermatitis in the Elderly: Predisposing Factors, Diagnosis, and Management.

Authors:  Ana Luiza Lima; Vanessa Timmermann; Tanja Illing; Peter Elsner
Journal:  Drugs Aging       Date:  2019-05       Impact factor: 3.923

Review 5.  Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options.

Authors:  Hilde Beele; Steven Smet; Nele Van Damme; Dimitri Beeckman
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

6.  Anti-fungal bandages containing cinnamon extract.

Authors:  Jubair Ahmed; Esra Altun; Mehmet O Aydogdu; Oguzhan Gunduz; Laxmi Kerai; Guogang Ren; Mohan Edirisinghe
Journal:  Int Wound J       Date:  2019-02-15       Impact factor: 3.315

7.  Antimicrobial Fibrous Bandage-like Scaffolds Using Clove Bud Oil.

Authors:  Carlota von Thadden; Esra Altun; Mehmet Aydogdu; Mohan Edirisinghe; Jubair Ahmed
Journal:  J Funct Biomater       Date:  2022-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.